PaySign, Inc.
NASDAQ Capital MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Mark R. Newcomer
- Full Time Employees
- 173
- Sector
- Technology
- Industry
- Software - Infrastructure
- Address
- 2615 Street Rose Parkway Henderson NV United States of America 89052
- IPO Date
- Oct 10, 2007
- CIK
- 0001496443
- Website
- paysign.com
- Similar Companies
- Business
- PaySign, Inc. (NASDAQ: PAYS) provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing solutions for businesses, consumers, and government institutions. Founded in 2001 and headquartered in Henderson, Nevada, the company offers customized payment solutions including corporate rewards and incentives; prepaid gift cards; general-purpose reloadable debit cards; employee incentives; consumer rebates; donor compensation for plasma centers; clinical trial payments; healthcare reimbursement and pharmaceutical payment assistance programs such as PharmaCash; demand deposit accounts accessible via debit cards; corporate disbursements; and a communication suite featuring kiosks, mobile apps, two-way SMS, text alerts, and a cardholder web portal, all marketed under the Paysign brand. It serves clients across pharmaceutical, healthcare, hospitality, retail, plasma donation, and municipal sectors primarily in the United States, with 3.1 million cardholders supported by 24/7 bilingual customer care, 99.999% platform uptime, and comprehensive services encompassing marketing, design, and compliance. In recent developments, PaySign acquired assets of Gamma Innovation LLC in March 2025, integrating advanced donor engagement tools, AI-driven retention apps, and SaaS platforms for plasma centers to enhance efficiency, reduce costs by 20-30%, add $4-5 million in annual cash flow, and expand into B2B payments; the acquisition included appointing Michael Ngo as Chief Innovation Officer and his key team members, further strengthening plasma industry capabilities amid 2025 Q1 revenue growth of 41%.
Paysign, Inc. to Present at the Planet MicroCap Las Vegas 2026
Paysign, Inc. to Present at the Planet MicroCap Las Vegas 2026
Paysign, Inc. to Present at the Barrington Research Virtual Spring Investment Conference
Paysign, Inc. to Present at the Barrington Research Virtual Spring Investment Conference
Why Paysign Plunged Today
Paysign, Inc. (PAYS) Q1 2026 Earnings Call Transcript
Breakfast News: Wix.com Pins Hopes on AI Tools
Paysign Q1 Earnings Call Highlights
Paysign's Patient Affordability Drives 51% Revenue Growth and Significant Margin Expansion for First Quarter 2026
Paysign to Host First Quarter 2026 Earnings Call
Paysign: The Market Is Finally Repricing A Pharma Margin Story
Paysign Is On A Roll
Paysign Q4 Earnings Call Highlights
Why Paysign Stock Is Skyrocketing Today
Paysign, Inc. (PAYS) Q4 2025 Earnings Call Transcript
Paysign, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results; Patient Affordability Drives 40% Revenue Growth and Significant Margin Expansion
Paysign, Inc. (NASDAQ:PAYS) Given Average Recommendation of “Moderate Buy” by Brokerages
Reviewing Paysign (NASDAQ:PAYS) & Marqeta (NASDAQ:MQ)
Paysign to Host Fourth Quarter and Full Year 2025 Earnings Call
Paysign, Inc. (NASDAQ:PAYS) Given Consensus Rating of “Moderate Buy” by Analysts